BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 27276746)

  • 21. Functional MRI for quantitative treatment response prediction in locally advanced rectal cancer.
    Pham TT; Liney GP; Wong K; Barton MB
    Br J Radiol; 2017 Apr; 90(1072):20151078. PubMed ID: 28055248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Could perfusion heterogeneity at dynamic contrast-enhanced MRI be used to predict rectal cancer sensitivity to chemoradiotherapy?
    Palmisano A; Esposito A; Rancoita PMV; Di Chiara A; Passoni P; Slim N; Campolongo M; Albarello L; Fiorino C; Rosati R; Del Maschio A; De Cobelli F
    Clin Radiol; 2018 Oct; 73(10):911.e1-911.e7. PubMed ID: 30029837
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting pathological response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer using 18FDG-PET/CT.
    Shanmugan S; Arrangoiz R; Nitzkorski JR; Yu JQ; Li T; Cooper H; Konski A; Farma JM; Sigurdson ER
    Ann Surg Oncol; 2012 Jul; 19(7):2178-85. PubMed ID: 22395978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Standardized Index of Shape (SIS): a quantitative DCE-MRI parameter to discriminate responders by non-responders after neoadjuvant therapy in LARC.
    Petrillo A; Fusco R; Petrillo M; Granata V; Sansone M; Avallone A; Delrio P; Pecori B; Tatangelo F; Ciliberto G
    Eur Radiol; 2015 Jul; 25(7):1935-45. PubMed ID: 25577525
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of diffusion-weighted MRI and MR volumetry in the evaluation of early treatment outcomes after preoperative chemoradiotherapy for locally advanced rectal cancer.
    Kim YC; Lim JS; Keum KC; Kim KA; Myoung S; Shin SJ; Kim MJ; Kim NK; Suh J; Kim KW
    J Magn Reson Imaging; 2011 Sep; 34(3):570-6. PubMed ID: 21751285
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Image Quality Assessment of 2D
    Hausmann D; Liu J; Budjan J; Reichert M; Ong M; Meyer M; Smakic A; Grimm R; Strecker R; Schoenberg SO; Wang X; Attenberger UI
    Anticancer Res; 2018 Feb; 38(2):969-978. PubMed ID: 29374729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rectal cancer: assessment of response to neoadjuvant chemoradiation by dynamic contrast-enhanced MRI.
    Oberholzer K; Menig M; Pohlmann A; Junginger T; Heintz A; Kreft A; Hansen T; Schneider A; Lollert A; Schmidberger H; Christoph D
    J Magn Reson Imaging; 2013 Jul; 38(1):119-26. PubMed ID: 23188618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.
    Capirci C; Rampin L; Erba PA; Galeotti F; Crepaldi G; Banti E; Gava M; Fanti S; Mariani G; Muzzio PC; Rubello D
    Eur J Nucl Med Mol Imaging; 2007 Oct; 34(10):1583-93. PubMed ID: 17503039
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
    Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
    Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nomogram for Predicting the Pathological Tumor Response from Pre-treatment Clinical Characteristics in Rectal Cancer.
    Kang BH; Song C; Kang SB; Lee KW; Lee HS; Kim JS
    Anticancer Res; 2020 Apr; 40(4):2171-2177. PubMed ID: 32234911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor volume reduction rate measured by magnetic resonance volumetry correlated with pathologic tumor response of preoperative chemoradiotherapy for rectal cancer.
    Yeo SG; Kim DY; Kim TH; Jung KH; Hong YS; Chang HJ; Park JW; Lim SB; Choi HS; Jeong SY
    Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):164-71. PubMed ID: 20004532
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Investigation of volumetric apparent diffusion coefficient histogram analysis for assessing complete response and clinical outcomes following pre-operative chemoradiation treatment for rectal carcinoma.
    Chidambaram V; Brierley JD; Cummings B; Bhayana R; Menezes RJ; Kennedy ED; Kirsch R; Jhaveri KS
    Abdom Radiol (NY); 2017 May; 42(5):1310-1318. PubMed ID: 28004138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Value of diffusion-weighted MRI and apparent diffusion coefficient measurements for predicting the response of locally advanced rectal cancer to neoadjuvant chemoradiotherapy.
    Iannicelli E; Di Pietropaolo M; Pilozzi E; Osti MF; Valentino M; Masoni L; Ferri M
    Abdom Radiol (NY); 2016 Oct; 41(10):1906-17. PubMed ID: 27323759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor volume regression during preoperative chemoradiotherapy for rectal cancer: a prospective observational study with weekly MRI.
    Van den Begin R; Kleijnen JP; Engels B; Philippens M; van Asselen B; Raaymakers B; Reerink O; De Ridder M; Intven M
    Acta Oncol; 2018 Jun; 57(6):723-727. PubMed ID: 29157069
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Value of percent change in tumoral volume measured at T
    Quaia E; Gennari AG; Ricciardi MC; Ulcigrai V; Angileri R; Cova MA
    J Magn Reson Imaging; 2016 Dec; 44(6):1415-1424. PubMed ID: 27219471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MRI predictive factors for tumor response in rectal cancer following neoadjuvant chemoradiation therapy--implications for induction chemotherapy?
    Yu SK; Tait D; Chau I; Brown G
    Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):505-11. PubMed ID: 24074924
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biopsy specimens obtained 7 days after starting chemoradiotherapy (CRT) provide reliable predictors of response to CRT for rectal cancer.
    Suzuki T; Sadahiro S; Tanaka A; Okada K; Kamata H; Kamijo A; Murayama C; Akiba T; Kawada S
    Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1232-8. PubMed ID: 23158058
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Modified 3-Point MRI-Based Tumor Regression Grade Incorporating DWI for Locally Advanced Rectal Cancer.
    Lee MA; Cho SH; Seo AN; Kim HJ; Shin KM; Kim SH; Choi GS
    AJR Am J Roentgenol; 2017 Dec; 209(6):1247-1255. PubMed ID: 28981353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinicopathological analysis of distal margin for rectal cancer after preoperative chemoradiation therapy.
    Nishioka M; Shimada M; Kurita N; Iwata T; Morimoto S; Yoshikawa K; Higashijima J; Miyatani T
    Hepatogastroenterology; 2012 Oct; 59(119):2142-6. PubMed ID: 22366527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors affecting the restaging accuracy of magnetic resonance imaging after preoperative chemoradiation in patients with rectal cancer.
    Kim IY; Cha SW; Ahn JH; Kim YW
    Eur J Surg Oncol; 2015 Apr; 41(4):493-8. PubMed ID: 25648465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.